Markus Pietsch

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Single Molecule

Photodynamic Therapy

Molecular Dynamics

Top Venues

International journal of molecular sciences

Histochemistry and cell biology

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Heerwig, Alfred Kick, Paul Sommerfeld, Sophia Eimermacher, Frederick Hartung, Markus Laube, Dietmar Fischer, Hans-Jürgen Pietzsch, Jens Pietzsch, Reik Löser, Michael Mertig, Markus Pietsch, Robert Wodtke
The Impact of N ε -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2. International journal of molecular sciences 24 (2) (2023)
Andreas Heerwig, Alfred Kick, Paul Sommerfeld, Sophia Eimermacher, Frederick Hartung, Markus Laube, Dietmar Fischer, Hans-Jürgen Pietzsch, Jens Pietzsch, Reik Löser, Michael Mertig, Markus Pietsch, Robert Wodtke
The Impact of N ε -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2. International journal of molecular sciences 24 (2) (2023)
Feodor Braun, Marcel Jaschinski, Philipp Täger, Verena Marmann, Melanie von Brandenstein, Barbara Köditz, Thomas Fischer, Sergio Muñoz-Vázquez, Beate Zimmermanns, Markus Dietlein, Ferdinand Sudbrock, Phillip Krapf, Dietmar Fischer, Axel Heidenreich, Alexander Drzezga, Stefan F Kirsch, Markus Pietsch, Klaus Schomäcker
Synthesis and evaluation of radioiodinated estrogens for diagnosis and therapy of male urogenital tumours. Organic & biomolecular chemistry (2023)
Andreas Heerwig, Alfred Kick, Paul Sommerfeld, Sophia Eimermacher, Frederick Hartung, Markus Laube, Dietmar Fischer, Hans-Jürgen Pietzsch, Jens Pietzsch, Reik Löser, Michael Mertig, Markus Pietsch, Robert Wodtke
The Impact of N ε -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2. International journal of molecular sciences 24 (2) (2023)
Andreas Heerwig, Alfred Kick, Paul Sommerfeld, Sophia Eimermacher, Frederick Hartung, Markus Laube, Dietmar Fischer, Hans-Jürgen Pietzsch, Jens Pietzsch, Reik Löser, Michael Mertig, Markus Pietsch, Robert Wodtke
The Impact of N ε -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2. International journal of molecular sciences 24 (2) (2023)
Andreas Heerwig, Alfred Kick, Paul Sommerfeld, Sophia Eimermacher, Frederick Hartung, Markus Laube, Dietmar Fischer, Hans-Jürgen Pietzsch, Jens Pietzsch, Reik Löser, Michael Mertig, Markus Pietsch, Robert Wodtke
The Impact of N ε -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2. International journal of molecular sciences 24 (2) (2023)
Galyna Pryymachuk, Ehab El-Awaad, Nadin Piekarek, Uta Drebber, Alexandra Claudia Maul, Juergen Hescheler, Andreas Wodarz, Gabriele Pfitzer, Wolfram F Neiss, Markus Pietsch, Mechthild M Schroeter
Angiotensin II type 1 receptor localizes at the blood-bile barrier in humans and pigs. Histochemistry and cell biology 157 (5) (2022)
Laura Schäkel, Salahuddin Mirza, Markus Pietsch, Sang-Yong Lee, Tim Keuler, Katharina Sylvester, Julie Pelletier, Jean Sévigny, Thanigaimalai Pillaiyar, Vigneshwaran Namasivayam, Michael Gütschow, Christa Elisabeth Müller
2-Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors. Archiv der Pharmazie 354 (12) (2021)
Dirk Lindenblatt, Mareike Horn, Claudia Götz, Karsten Niefind, Ines Neundorf, Markus Pietsch
Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells. ChemMedChem 14 (8) (2019)
Florian M Dato, Miriam Sheikh, Rocky Z Uhl, Alexandra W Schüller, Michaela Steinkrüger, Peter Koch, Jörg-Martin Neudörfl, Michael Gütschow, Bernd Goldfuss, Markus Pietsch
ω-Phthalimidoalkyl Aryl Ureas as Potent and Selective Inhibitors of Cholesterol Esterase. ChemMedChem 13 (17) (2018)